InvestorsHub Logo
Followers 228
Posts 12704
Boards Moderated 0
Alias Born 04/13/2007

Re: pauljack13 post# 1035

Tuesday, 03/21/2017 2:59:01 PM

Tuesday, March 21, 2017 2:59:01 PM

Post# of 3308
Also, the company said that the market for Oral Endoxifen was $2 billion in its Power Point presentation that I relied upon purchase of shares from ATOS. Now, the SEC filing from today says the market is only $1 billion i.e. the potential market was severely cut in half. Management's estimates were BAD!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ATOS News